Spring 2026

A Note from the Co-Directors, Spring 2026

A Note from the Co-Directors, Spring 2026

Dear Partners & Allies,

Did you know that an estimated 8.5 to 10 million adults on Medicaid are living with conditions that may benefit from psychedelic-assisted therapy and are not finding adequate relief through existing treatment options?

The executive order issued earlier this spring to accelerate the approval of breakthrough therapies for serious mental illness reinforced the importance of our mission. As the path toward approval accelerates, so does the need to ensure that public systems are ready—with the evidence, care models, and reimbursement pathways required to deliver safe, effective, and sustainable access at scale. That is the work of PMHA Alliance.

In this Spring Update, we're excited to share progress from across that effort, including major milestones in New Mexico and New Jersey, the launch of recruitment for our first pilot cohorts, and our new website, www.pmhaa.org. To everyone helping make this work possible—thank you. The groundwork we build today will help determine how quickly and how broadly these therapies can reach the people who need them most.

We'd love to connect and share more about PMHA Alliance's vision and five-year strategy for building the infrastructure needed to bring psychedelic-assisted therapy into public funding systems and expand access at scale. To schedule a conversation with our team, please contact Mary Lim at mary@pmhaa.org.

With gratitude,
Hanifa & Dara

Hanifa Nayo Washington and Dara Menashi

More from Spring 2026

← All updatesSee PMHA in the Press & Media →